NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER

• 收藏
• 分享

专利权人:

Rhizen Pharmaceuticals SA

发明人:

Meyyappan Muthuppalaniappan,Srikant Viswanadha,Kanthikiran V.S. Varanasi,Gayatri Swaroop Merikapudi,Swaroop Kumar V.S. Vakkalanka

申请号：

US16168499

公开号：

US20190248791A1

申请日:

2018.10.23

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/